Mrs. Feryal Dabbagh-Gorjani – Tumor Immunology – Best Researcher Award

Posted on by Pencis

Mrs. Feryal Dabbagh-Gorjani - Tumor Immunology - Best Researcher Award

Foroogh Salamat - Iran

Author Profile

Orcid

EARLY ACADEMIC PURSUITS

Feryal Dabbagh Gorjani embarked on her academic journey with a strong foundation in the medical sciences. She pursued a B.Sc in Clinical Laboratory from 2008 to 2010 at the Preclinical School of Iran University of Medical Science, Tehran, Iran. Prior to that, she obtained an associated degree in Clinical Laboratory from the Preclinical School of Islamic Azad University, Tehran Medical Sciences Branch, from 2005 to 2007. Her educational journey culminated in an M.Sc in Medical Immunology from 2011 to 2014 at the Medical School of Shiraz University of Medical Science, Shiraz, Iran.

PROFESSIONAL ENDEAVORS

From December 2023 onwards, Feryal Dabbagh Gorjani has been engaged as a medical advisor at Forough Salamat Mehregan, the official representative of the American company Fairhaven Health. Her role in this capacity involves providing expertise and guidance in medical matters, presumably within the realm of immunology and clinical laboratory science.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Throughout her academic and professional journey, Feryal Dabbagh Gorjani has likely contributed to the field of medical immunology and clinical laboratory science. And her Specific research focuses on immunological diagnostics, disease pathogenesis, and therapeutic interventions.

IMPACT AND INFLUENCE

Her work as a medical advisor suggests that she plays a crucial role in shaping decisions related to health and wellness. Her expertise in medical immunology and clinical laboratory science likely contributes to advancements in diagnostic accuracy, treatment efficacy, and patient care.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

Feryal Dabbagh Gorjani's legacy and future contributions lie in her ongoing work as a medical advisor and her potential for further advancements in the fields of medical immunology and clinical laboratory science. As she continues to apply her expertise and knowledge in healthcare settings, her contributions are likely to impact patient outcomes, research advancements, and the broader medical community. Future endeavors may include continued research, publications, and collaborative efforts to address emerging challenges in immunological diagnostics and therapeutics.

Notable Publications

A Comprehensive Review on the Role of Interleukin-40 as a Biomarker for Diagnosing Inflammatory Diseases. 2024

COVID-19 and neurological complications. 2022

EcoImmunology: Evaluative Aspects and Future Perspectives. 2018

Investigating the Association of IL-17A and IL-17F with Susceptibility to Preeclampsia in Iranian Women. 2015

Differences in the expression of TLRs and inflammatory cytokines in preeclamptic compared with healthy pregnant women. 2014

 

 

 

 

Prof Dr. Qiao Li – Tumor Immunology – Best Researcher Award

Posted on by Pencis

Prof Dr. Qiao Li - Tumor Immunology - Best Researcher Award

University of Michigan - United States

AUTHOR PROFILE

Scopus

EARLY ACADEMIC PURSUITS

Qiao Li, Ph.D., embarked on her academic journey with a Bachelor's degree in Microbiology from Wuhan University, Wuhan, P.R. China, in 1982. Continuing her pursuit of knowledge, she obtained a Master's degree in Environmental Biology from the Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, P.R. China, in 1985. These early academic pursuits laid the foundation for her comprehensive training in the biological sciences.

PROFESSIONAL ENDEAVORS

In 1994, Qiao Li achieved a Ph.D. in Biological Sciences from Wayne State University, Detroit, Michigan, USA. Subsequently, she assumed the role of Research Professor of Tumor Immunology and Immunotherapy at the University of Michigan Medical School, Ann Arbor, Michigan, USA. Her professional endeavors showcase a commitment to advancing the understanding and treatment of cancer through immunological approaches.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUMOR IMMUNOLOGY

Qiao Li's contributions extend beyond her role as a Research Professor. As a Section Editor or Editorial Board Member for the International Journal of Biological Sciences, she actively contributes to the dissemination of scientific knowledge. Her research focus lies in Tumor Immunology and Cancer Immunotherapy, where she explores innovative strategies to harness the immune system for effective cancer treatment.

IMPACT AND INFLUENCE

Qiao Li's impact is evident in her multifaceted role, including positions such as Section Editor and Editorial Board Member. Her influence extends to teaching, research mentorship, and overseeing graduate student committees at the University of Michigan. As a Research Professor, she contributes significantly to the advancement of tumor immunology, leaving a lasting imprint on the academic and research community.

ACADEMIC CITES

Qiao Li's involvement as a Section Editor and Editorial Board Member suggests that her work likely receives recognition within the academic community. Her contributions to the International Journal of Biological Sciences and other scholarly activities contribute to the dissemination and acknowledgment of her expertise in the field.

LEGACY AND FUTURE CONTRIBUTIONS HIGHLIGHT

Qiao Li's legacy is built upon her extensive involvement in education, research mentorship, and editorial roles. Her commitment to supervising undergraduate and graduate students, along with her contribution to medical student educational activities, underscores her dedication to fostering the next generation of scientists. Looking ahead, Qiao Li is poised to continue making significant contributions to tumor immunology and cancer immunotherapy, leaving a lasting legacy through her ongoing research, mentorship, and editorial responsibilities. Her role in training international Ph.D. students further signifies a global impact in the field of cancer research.

NOTABLE PUBLICATIONS

Cancer stem cell antigen nanodisc cocktail elicits anti-tumor immune responses in melanoma. 2022

Efficacy of an ALDH peptide-based dendritic cell vaccine targeting cancer stem cells. 2022

Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity. 2022

CPNE8 Promotes Gastric Cancer Metastasis by Modulating Focal Adhesion Pathway and Tumor Microenvironment. 2022

Targeting cancer stem cells via integrin Ī²4. 2022

Assoc Prof Dr.BOU KHALIL Rami – Pharmaco – Oncology – Best Researcher Award

Posted on by Pencis

Assoc Prof Dr.BOU KHALIL Rami - Pharmaco - Oncology - Best Researcher Award

Hotel Dieu de France / Saint-Joseph University - Lebanon

AUTHOR PROFILE

Scopus

Google Scholar

Orchid

EARLY ACADEMIC PURSUITS:

Dr. Bou Khalil began his academic journey in the field of medicine at Saint-Joseph University, Lebanon, where he completed his medical doctorate in 2006. His early academic pursuits laid the foundation for his subsequent specialization in psychiatry.

PROFESSIONAL ENDEAVORS:

Dr. Bou Khalil has amassed a wealth of clinical experience throughout his distinguished career. Notably, he has served as the Head of the Psychiatry Department at Hotel-Dieu de France in Beirut since March 2023. His clinical practice spans various settings, including private clinics, psychiatric hospitals, and addiction treatment centers. Dr. Bou Khalil has demonstrated his commitment to mental health by providing comprehensive care to patients of all ages and managing diverse mental disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACO-ONCOLOGY

With a strong emphasis on research, Dr. Bou Khalil earned his Ph.D. from Montpellier University, France, focusing on eating disorders,Ā  psychological trauma and pharmaco-oncology. His extensive research portfolio includes investigations into topics such as the use of psychotropic drugs in oncology patients, the efficacy of Mifepristone in treating anorexia nervosa models, and the metabolic syndrome in Lebanese patients with schizophrenia. These contributions underscore his dedication to advancing knowledge in the field of psychiatry.

IMPACT AND INFLUENCE:

Dr. Bou Khalil's influence extends beyond clinical practice and research. He has played a pivotal role in various institutions, including serving as a Consultant Psychiatrist for patients with addiction at SIDC, Beirut, and contributing as a Mental Health Supervisor for the program supporting Syrian refugees. His impact is evident in his roles as a member of the scientific committee for exemption from official exams in the Lebanese Ministry of Education and as a member of the scientific committee of psychiatry in the Ministry of Public Health.

ACADEMIC CITES:

Dr. Bou Khalil's academic journey has been marked by significant achievements. He holds the position of Associate Professor of Psychiatry at Saint-Joseph University, Beirut, since December 2023. His academic contributions also include serving as an Assistant Professor and Lecturer at the university's departments of psychiatry, psychology, nursing, and the faculty of medicine. His commitment to medical education is further highlighted by obtaining a Master's degree in medical education techniques.

LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Bou Khalil's legacy is shaped by his multifaceted contributions to clinical practice, research, and education. His extensive involvement with organizations like the Jesuit Refugee Service and Doctors Without Borders showcases his commitment to global mental health. As an academician, clinician, and researcher, his future contributions are anticipated to continue shaping the landscape of psychiatry and mental health care in Lebanon and beyond.

NOTABLE PUBLICATION

Clinical Correlates of Measured and Predicted Resting Energy Expenditure in Patients with Anorexia Nervosa: A Retrospective Cohort Study. Nutrients.

Neutrophil-to-lymphocyte ratio (NLR) variations in relationship with childhood maltreatment in patients with anorexia nervosa: a retrospective cohort study

The impact of lockdown and other stressors during the COVID-19 pandemic on depression and anxiety in a Lebanese opportunistic sample: an online cross-sectional survey